94 related articles for article (PubMed ID: 27654712)
1. Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer.
Lee KW; Lee SS; Hwang JE; Jang HJ; Lee HS; Oh SC; Lee SH; Sohn BH; Kim SB; Shim JJ; Jeong W; Cha M; Cheong JH; Cho JY; Lim JY; Park ES; Kim SC; Kang YK; Noh SH; Ajani JA; Lee JS
Clin Cancer Res; 2016 Dec; 22(24):6228-6235. PubMed ID: 27654712
[TBL] [Abstract][Full Text] [Related]
2. Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer.
Ghosh P; Tie J; Muranyi A; Singh S; Brunhoeber P; Leith K; Bowermaster R; Liao Z; Zhu Y; LaFleur B; Tran B; Desai J; Jones I; Croxford M; Jover R; Goel A; Waring P; Hu S; Teichgraber V; Rohr UP; Ridder R; Shanmugam K; Gibbs P
Clin Cancer Res; 2016 Jul; 22(14):3488-98. PubMed ID: 27029492
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
4. A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies.
Rini B; Goddard A; Knezevic D; Maddala T; Zhou M; Aydin H; Campbell S; Elson P; Koscielny S; Lopatin M; Svedman C; Martini JF; Williams JA; Verkarre V; Radulescu C; Neuzillet Y; Hemmerlé I; Timsit MO; Tsiatis AC; Bonham M; Lebret T; Mejean A; Escudier B
Lancet Oncol; 2015 Jun; 16(6):676-85. PubMed ID: 25979595
[TBL] [Abstract][Full Text] [Related]
5. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.
Gray RG; Quirke P; Handley K; Lopatin M; Magill L; Baehner FL; Beaumont C; Clark-Langone KM; Yoshizawa CN; Lee M; Watson D; Shak S; Kerr DJ
J Clin Oncol; 2011 Dec; 29(35):4611-9. PubMed ID: 22067390
[TBL] [Abstract][Full Text] [Related]
6. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy.
Mortensen MM; Høyer S; Lynnerup AS; Ørntoft TF; Sørensen KD; Borre M; Dyrskjøt L
Sci Rep; 2015 Nov; 5():16018. PubMed ID: 26522007
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer.
Takeno A; Takemasa I; Seno S; Yamasaki M; Motoori M; Miyata H; Nakajima K; Takiguchi S; Fujiwara Y; Nishida T; Okayama T; Matsubara K; Takenaka Y; Matsuda H; Monden M; Mori M; Doki Y
Ann Surg Oncol; 2010 Apr; 17(4):1033-42. PubMed ID: 20012501
[TBL] [Abstract][Full Text] [Related]
9. Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery.
Lee J; Sohn I; Do IG; Kim KM; Park SH; Park JO; Park YS; Lim HY; Sohn TS; Bae JM; Choi MG; Lim DH; Min BH; Lee JH; Rhee PL; Kim JJ; Choi DI; Tan IB; Das K; Tan P; Jung SH; Kang WK; Kim S
PLoS One; 2014; 9(3):e90133. PubMed ID: 24598828
[TBL] [Abstract][Full Text] [Related]
10. Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer.
Lee IS; Sahu D; Hur H; Yook JH; Kim BS; Goel A
Gastric Cancer; 2021 May; 24(3):655-665. PubMed ID: 33523340
[TBL] [Abstract][Full Text] [Related]
11. Circular RNAs signature predicts the early recurrence of stage III gastric cancer after radical surgery.
Zhang Y; Li J; Yu J; Liu H; Shen Z; Ye G; Mou T; Qi X; Li G
Oncotarget; 2017 Apr; 8(14):22936-22943. PubMed ID: 28206972
[TBL] [Abstract][Full Text] [Related]
12. Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.
Shan Z; Wang W; Tong Y; Zhang J
Med Sci Monit; 2021 Mar; 27():e929558. PubMed ID: 33758160
[TBL] [Abstract][Full Text] [Related]
13. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer.
Kim SK; Roh YG; Park K; Kang TH; Kim WJ; Lee JS; Leem SH; Chu IS
Clin Cancer Res; 2014 Jun; 20(12):3233-43. PubMed ID: 24714775
[TBL] [Abstract][Full Text] [Related]
14. Nomogram for predicting gastric cancer recurrence using biomarker gene expression.
Jeong SH; Kim RB; Park SY; Park J; Jung EJ; Ju YT; Jeong CY; Park M; Ko GH; Song DH; Koh HM; Kim WH; Yang HK; Lee YJ; Hong SC
Eur J Surg Oncol; 2020 Jan; 46(1):195-201. PubMed ID: 31564475
[TBL] [Abstract][Full Text] [Related]
15. Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients.
Yang SH; Seo MY; Jeong HJ; Jeung HC; Shin J; Kim SC; Noh SH; Chung HC; Rha SY
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):612-20. PubMed ID: 15701848
[TBL] [Abstract][Full Text] [Related]
16. MiR 21-5p as a predictor of recurrence in young gastric cancer patients.
Park SK; Park YS; Ahn JY; Do EJ; Kim D; Kim JE; Jung K; Byeon JS; Ye BD; Yang DH; Park SH; Hwang SW; Jung HY; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1429-35. PubMed ID: 26824898
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
18. Association of family history with cancer recurrence and survival in patients with gastric cancer.
Han MA; Oh MG; Choi IJ; Park SR; Ryu KW; Nam BH; Cho SJ; Kim CG; Lee JH; Kim YW
J Clin Oncol; 2012 Mar; 30(7):701-8. PubMed ID: 22271486
[TBL] [Abstract][Full Text] [Related]
19. Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer.
Yang L; Yang S; Liu J; Wang X; Ji J; Cao Y; Lu K; Wang J; Gao Y
Exp Mol Pathol; 2014 Apr; 96(2):235-41. PubMed ID: 24602846
[TBL] [Abstract][Full Text] [Related]
20. Prediction of recurrence in advanced gastric cancer patients after curative resection by gene expression profiling.
Motoori M; Takemasa I; Yano M; Saito S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Doki Y; Kurokawa Y; Ueno N; Oba S; Ishii S; Monden M; Kato K
Int J Cancer; 2005 May; 114(6):963-8. PubMed ID: 15645432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
